Kunming Saturn Bio-technology(Group)CO.,ltd.

Industry

Digital & robotics, Feed, Food ingredients, Industrial chemistry, Paints & coatings

Topics

Animal feed & feed additives, Enzymes & biocatalysis

Role

Research / RTO — “…neering and MoE engineering research center) [1]. Reported scale: 7 employees (51–200 per one profile) [1]. Ke…”

Why it is bioeconomy

Kunming Saturn Bio-technology (Group) Co., Ltd. is a biotechnology company specializing in the research, development, and production of animal nutrition solutions, feed additives, enzymes, and probiotics.

Found via

[Rubric] China · methane-feed

Not yet cited as a supplier in a graded solution.

Subsidiaries: 幸福公社电子商务有限公司 (Xingfu Gongshe E-commerce Co., Ltd.) · 中畜肉牛产业服务有限公司 (Zhongchu Beef Cattle Industry Service Co., Ltd.) · 诺本科技有限公司 (Noben Science & Technology Co., Ltd.) · Saturn Bio Vietnam Co Ltd (Công Ty TNHH Khoa Học Kỹ Thuật Saturn Bio)

• 2026-09-07 昆企打造疫苗“中国芯”_昆明信息港
  Kunming JianDa Biotech (昆明简达生物技术有限公司) announced major progress: its liver cancer therapeutic vaccine completed pilot testing in Nanjing and its next-generation recombinant influenza vaccine received FDA clinical trial approval, making it the first Chinese …
• 2026-07-27 云南省重组流感疫苗首获FDA临床试验许可_昆明信息港
  Kunming Saturn Bio-technology (Group) Co., Ltd. (简达生物技术（昆明）有限公司)自主研发的重组蛋白流感疫苗获得FDA临床试验许可，标志其成为云南省第一个进入国际临床阶段的重组流感疫苗项目，其核心创新是自主研发的 CpG复合佐剂系统，该系统提升免疫反应并在低抗原剂量下实现强保护。
• 2026-07-14 云南生物医药迎历史性跨越：首款重组流感疫苗获美国FDA临床批件，开启流感疫苗“换代”新纪元_昆明信息港
  Kunming Saturn Bio-technology (Group) Co., Ltd. is highlighted as the developer of a next-generation recombinant influenza vaccine that received FDA clinical trial approval, marking a historic milestone for the company and positioning Kunming/Yunnan as a …
• 2026-08-06 “滇中新区产”三价HPV疫苗获批上市_县域经济_昆明频道_云南网
  Summary: The article states that Kang Le Wei Shi (Kunming) Biotechnologies Co., Ltd. received the national drug administration approval for a trivalent HPV vaccine produced at its Kunming facility in the Dianhong New District, marking its move toward …
• 2026-07-15 昆明理工大学生命科学与技术学院原创新药研发成果成功转化落地-昆明理工大学生命科学与技术学院
  Kunming Saturn Bio-technology (Group) Co., Ltd. is formed to industrialize the HB-58 anti-HBV candidate, created by Prof. Xu Min’s team at KMUT Life Sciences & Technology College, leveraging IP-valued equity and university–industry collaboration to advance an …
• 2026-09-07 昆明高新区新增一省级技术创新中心_昆明信息港
  The article states that Kunming High-tech Zone, led by Yunnan Plant Pharmaceutical Co., Ltd. (Yun Zhi Yao Ye), has had the “Yunnan Province Specialty Drug Formulation R&D and Transformation Technology Innovation Center” approved as a provincial tech innovation …

Ownership & investors 4